• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

存在部分异方差性时的多重对比检验。

Multiple Contrast Tests in the Presence of Partial Heteroskedasticity.

作者信息

Hasler Mario, Birr Tim, Hothorn Ludwig A

机构信息

Lehrfach Variationsstatistik, Christian-Albrechts-University of Kiel, Kiel, Germany.

Department of Plant Diseases and Crop Protection, Institute of Phytopathology, Christian-Albrechts-University of Kiel, Kiel, Germany.

出版信息

Biom J. 2025 Feb;67(1):e70019. doi: 10.1002/bimj.70019.

DOI:10.1002/bimj.70019
PMID:39806525
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11729621/
Abstract

This paper proposes a general approach for handling multiple contrast tests for normally distributed data in the presence of partial heteroskedasticity. In contrast to the usual case of complete heteroskedasticity, the treatments belong to subgroups according to their variances. Treatments within these subgroups are homoskedastic, whereas treatments of different subgroups are heteroskedastic. New candidate as well as already existing approaches are described and compared by -simulations. Power simulations show that a gain in power is achieved when the partial heteroskedasticity is taken into account compared to procedures which wrongly assume complete heteroskedasticity. The new approaches will be applied to a phytopathological experiment.

摘要

本文提出了一种在存在部分异方差性的情况下处理正态分布数据多重对比检验的通用方法。与完全异方差性的常见情况不同,处理根据其方差属于不同的子组。这些子组内的处理是同方差的,而不同子组的处理是异方差的。通过模拟描述并比较了新的候选方法以及现有的方法。功效模拟表明,与错误假定完全异方差性的程序相比,考虑部分异方差性时功效会有所提高。新方法将应用于一项植物病理学实验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be5/11729621/45e80f0ec253/BIMJ-67-e70019-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be5/11729621/e45b044687fb/BIMJ-67-e70019-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be5/11729621/8d5735dbf886/BIMJ-67-e70019-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be5/11729621/7abcfe953ce0/BIMJ-67-e70019-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be5/11729621/08dc7fcd57b5/BIMJ-67-e70019-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be5/11729621/069211d955e3/BIMJ-67-e70019-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be5/11729621/f589ff108d05/BIMJ-67-e70019-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be5/11729621/45e80f0ec253/BIMJ-67-e70019-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be5/11729621/e45b044687fb/BIMJ-67-e70019-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be5/11729621/8d5735dbf886/BIMJ-67-e70019-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be5/11729621/7abcfe953ce0/BIMJ-67-e70019-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be5/11729621/08dc7fcd57b5/BIMJ-67-e70019-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be5/11729621/069211d955e3/BIMJ-67-e70019-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be5/11729621/f589ff108d05/BIMJ-67-e70019-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be5/11729621/45e80f0ec253/BIMJ-67-e70019-g001.jpg

相似文献

1
Multiple Contrast Tests in the Presence of Partial Heteroskedasticity.存在部分异方差性时的多重对比检验。
Biom J. 2025 Feb;67(1):e70019. doi: 10.1002/bimj.70019.
2
Multiple contrast tests in the presence of heteroscedasticity.异方差情况下的多重对比检验。
Biom J. 2008 Oct;50(5):793-800. doi: 10.1002/bimj.200710466.
3
Multiple-breed genetic inference using heavy-tailed structural models for heterogeneous residual variances.使用重尾结构模型对异质残差方差进行多品种遗传推断。
J Anim Sci. 2005 Aug;83(8):1766-79. doi: 10.2527/2005.8381766x.
4
Genomic Prediction Accounting for Residual Heteroskedasticity.考虑残余异方差性的基因组预测
G3 (Bethesda). 2015 Nov 12;6(1):1-13. doi: 10.1534/g3.115.022897.
5
Accounting for outliers and heteroskedasticity in multibreed genetic evaluations of postweaning gain of Nelore-Hereford cattle.考虑在肉牛-赫里福德牛断奶后增重的多品种遗传评估中的异常值和异方差性。
J Anim Sci. 2007 Apr;85(4):909-18. doi: 10.2527/jas.2006-668. Epub 2006 Dec 18.
6
Exploring the importance of controlling heteroskedasticity and heterogeneity in health valuation: a case study on Dutch EQ-5D-5L.探讨控制健康估值中异方差和异质性的重要性:以荷兰 EQ-5D-5L 为例。
Health Qual Life Outcomes. 2022 May 25;20(1):85. doi: 10.1186/s12955-022-01989-9.
7
Multiplicity adjustments for the Dunnett procedure under heterokcedasticity.异方差性下Dunnett方法的多重性调整
Biom J. 2023 Dec;65(8):e2200300. doi: 10.1002/bimj.202200300. Epub 2023 Oct 3.
8
A multiple comparison procedure for dose-finding trials with subpopulations.一种用于亚组剂量探索试验的多重比较方法。
Biom J. 2020 Jan;62(1):53-68. doi: 10.1002/bimj.201800111. Epub 2019 Sep 23.
9
Improved power of familywise error rate procedures for discrete data under dependency.相依性下离散数据的家族性错误率程序的功效改进
Biom J. 2019 Jan;61(1):101-114. doi: 10.1002/bimj.201700332.
10
Simultaneous treatment of unspecified heteroskedastic model error distribution and mismeasured covariates for restricted moment models.受限矩模型中未指定的异方差模型误差分布与测量误差协变量的同时处理
J Econom. 2017 Oct;200(2):194-206. doi: 10.1016/j.jeconom.2017.06.005. Epub 2017 Jul 8.

本文引用的文献

1
Multi-arm trials with multiple primary endpoints and missing values.多臂试验,多个主要终点,存在缺失值。
Stat Med. 2018 Feb 28;37(5):710-721. doi: 10.1002/sim.7542. Epub 2017 Nov 6.
2
Multiple contrast tests for multiple endpoints in the presence of heteroscedasticity.存在异方差性时针对多个终点的多重对比检验。
Int J Biostat. 2014;10(1):17-28. doi: 10.1515/ijb-2012-0015.
3
Multiple comparisons to both a negative and a positive control.与阴性和阳性对照进行多次比较。
Pharm Stat. 2012 Jan-Feb;11(1):74-81. doi: 10.1002/pst.503. Epub 2012 Jan 10.
4
A robust procedure for comparing multiple means under heteroscedasticity in unbalanced designs.一种在非平衡设计中针对异方差比较多个均值的稳健方法。
PLoS One. 2010 Mar 29;5(3):e9788. doi: 10.1371/journal.pone.0009788.
5
An approximate distribution of estimates of variance components.方差分量估计值的近似分布。
Biometrics. 1946 Dec;2(6):110-4.
6
Multiple contrast tests in the presence of heteroscedasticity.异方差情况下的多重对比检验。
Biom J. 2008 Oct;50(5):793-800. doi: 10.1002/bimj.200710466.
7
A randomized, double-blind, placebo-controlled phase II dose-finding study of the novel anti-muscarinic agent imidafenacin in Japanese patients with overactive bladder.一项针对日本膀胱过度活动症患者的新型抗毒蕈碱药物咪达非那新的随机、双盲、安慰剂对照II期剂量探索研究。
Int J Urol. 2008 Sep;15(9):809-15. doi: 10.1111/j.1442-2042.2008.02104.x. Epub 2008 Jul 10.
8
Power and Type I errors for pairwise comparisons of means in the unequal variances case.方差不等情况下均值两两比较的检验效能与I型错误
Br J Math Stat Psychol. 2009 May;62(Pt 2):263-81. doi: 10.1348/000711008X291542. Epub 2008 Mar 7.
9
Assessing non-inferiority of a new treatment in a three-arm trial in the presence of heteroscedasticity.在存在异方差性的三臂试验中评估新治疗方法的非劣效性。
Stat Med. 2008 Feb 20;27(4):490-503. doi: 10.1002/sim.3052.
10
Biostatistical assessment of mutagenicity studies by including the positive control.通过纳入阳性对照对致突变性研究进行生物统计学评估。
Biom J. 2005 Feb;47(1):82-7; discussion 99-107. doi: 10.1002/bimj.200410082.